Marshall Wace’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-440,668	Closed	-$58.1M	–	3335
2025 Q1	$58.1M	Sell	440,668 -639,089	-59%	-$79.6M	0.08%	243
2024 Q4	$90.2M	Sell	1,079,757 -81,216	-7%	-$6.67M	0.11%	171
2024 Q3	$84.9M	Buy	1,160,973 +661,958	+133%	+$49.8M	0.11%	172
2024 Q2	$34.2M	Buy	+499,015	New	+$34.6M	0.05%	338
2024 Q1	–	Sell	-24,249	Closed	-$1.74M	–	2945
2023 Q4	$1.74M	Sell	24,249 -18,699	-44%	-$1.08M	﹤0.01%	1279
2023 Q3	$2.24M	Sell	42,948 -65,500	-60%	-$3.82M	﹤0.01%	1174
2023 Q2	$6.87M	Buy	+108,448	New	+$6.76M	0.01%	892
2022 Q2	–	Sell	-2,519,764	Closed	-$154M	–	4065
2022 Q1	$154M	Buy	2,519,764 +131,470	+6%	+$6.83M	0.32%	59
2021 Q4	$125M	Buy	2,388,294 +92,660	+4%	+$3.89M	0.25%	82
2021 Q3	$85.6M	Sell	2,295,634 -475,670	-17%	-$16.5M	0.42%	35
2021 Q2	$113M	Sell	2,771,304 -63,156	-2%	-$2.33M	0.6%	23
2021 Q1	$96.2M	Sell	2,834,460 -181,272	-6%	-$6.29M	0.51%	33
2020 Q4	$95.9M	Buy	3,015,732 +3,355	+0.1%	+$88.2K	0.61%	34
2020 Q3	$77.3M	Buy	3,012,377 +1,694,447	+129%	+$38.7M	0.57%	38
2020 Q2	$33.8M	Buy	1,317,930 +633,152	+92%	+$12.8M	0.26%	95
2020 Q1	$10.5M	Buy	+684,778	New	+$14.9M	0.11%	203
2016 Q3	–	Sell	-9,820	Closed	-$381K	–	1167
2016 Q2	$381K	Buy	+9,820	New	+$353K	﹤0.01%	871
2016 Q1	–	Sell	-23,148	Closed	-$1.25M	–	1213
2015 Q4	$1.25M	Buy	23,148 +4,410	+24%	+$222K	0.01%	664
2015 Q3	$750K	Buy	+18,738	New	+$611K	0.01%	671

Other funds holding ITCI